
Work Here?
Waystar provides cloud-based payments technology that unifies and simplifies healthcare payments for providers, payers, and patients. Its platform integrates with major health information systems and practice management systems to streamline workflows, improve healthcare financials, and increase transparency in the patient financial experience. The platform serves more than 450,000 providers, 750 health systems and hospitals, and 5,000 health plans. By connecting with existing HIS and practice management tools, it enables centralized payment processing, billing, and patient billing experiences across the healthcare ecosystem. Waystar differentiates itself through its large network of integrations, cloud-based delivery, and a focus on end-to-end payment workflows that improve financial operations and patient experience. The goal is to simplify and unify healthcare payments, helping providers get paid faster and patients understand and manage their medical bills more clearly.
Industries
Enterprise Software
Fintech
Financial Services
Healthcare
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Louisville, Kentucky
Founded
2000
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$967.5M
Above
Industry Average
Funded Over
2 Rounds
401(k) matching: We’re proud to help our team members build their financial futures with a range of investment options available.
Career mobility: We’re all about professional growth. In 2018, roughly 15% of our team members stepped into a new role within the company.
Waystar welcome: Our weeklong onboarding program positions introduces our company and leadership team and positions every new hire for success.
Family friendly: Waystar offers paid leave for maternity, paternity and adoption and prioritizes work-life balance for all team members.
WAY stock surges on reported sale buzz - RBC flags this tech giant as the 'obvious first name' Published: Sep 15 2026, 10:15 PM IST * FB * TW * Linkdin * Whatsapp * GNFollow Us * RBC Capital maintains an 'Outperform' rating and $44 price target on Waystar, according to The Fly. * RBC picked Oracle as its first choice as a potential acquirer. * Evercore ISI said exploring a deal makes sense for Waystar, given the stock's roughly 24% decline this year. Waystar (WAY) shares jumped more than 8% on Tuesday after a report said the healthcare software company is exploring a potential sale, with RBC Capital naming Oracle (ORCL) as the "obvious first name" among potential strategic buyers. According to a Reuters report on Tuesday, Waystar has hired investment bank Evercore to explore strategic options, including a potential sale. The process is still in its early stages, and there is no guarantee a deal will happen, the report added. A sale could return Waystar to private ownership roughly two years after its 2024 market debut. Waystar provides software that helps hospitals and doctors manage payments and automate administrative work. According to Fiscal.ai, Canada Pension Plan Investment Board, BCPE Derby (De) SPV, and EQT are the three top shareholders. RBC highlights potential acquirers. RBC analyst Ryan Halsted said the number of sources cited in the Reuters report gives it credibility and expects Waystar shares to move higher following the news. The analyst said private-market valuations for healthcare software companies have remained stronger than public-market valuations, potentially making Waystar an attractive acquisition target. RBC added that while private-equity firms could be potential buyers, the list of potential strategic acquirers is relatively short. RBC called Oracle the "obvious first name," followed by UnitedHealth Group's (UNH) Optum. However, it noted that Optum could face regulatory scrutiny, while Oracle is already focused on heavy spending and debt related to its AI expansion. RBC Capital maintains an 'Outperform' rating and $44 price target on Waystar, according to The Fly. This implies a 64% upside potential from current levels. Evercore says sale would make sense. Evercore ISI called the report "surprising" but said exploring a deal makes sense given Waystar's roughly 24% decline this year. The firm said management could be looking for ways to maximize shareholder value following the stock's weakness. Evercore maintained an 'Outperform' rating and $28 price target. Retail's take on WAY. Retail sentiment surrounding WAY on Stocktwits remained in the 'bearish' zone over the past 24 hours. WAY stock has slid almost 18% in 2026. Also read: Eli Lilly To Present Fresh Data On Foundayo, Retatrutide In Europe - Here's Why Berenberg Sees A 21% Potential Upside In LLY Stock For updates and corrections, email newsroom[at]stocktwits[dot]com.< Stay updated with all the latest Business News, including market trends, Share Market News, stock updates, taxation, IPOs, banking, finance, real estate, savings, and investments. Track daily Gold Price changes, updates on DA Hike, and the latest developments on the 8th Pay Commission. Get in-depth analysis, expert opinions, and real-time updates to make informed financial decisions. Download the Asianet News Official App from the Android Play Store and iPhone App Store to stay ahead in business. 0 Comments / 0 New
Exclusive-Healthcare software firm Waystar explores options including sale, sources say. By Thomson Reuters Sep 15, 2026 | 6:05 AM By Isla Binnie, Sabrina Valle and Milana Vinn NEW YORK, Sept 15 (Reuters) - Software provider Waystar, whose products are used by hospitals and doctors to manage payments, is exploring options including a potential sale that could return it to private hands two years after a stock market listing in New York, seven sources familiar with the matter said. The Lehi, Utah, and Louisville, Kentucky-based company has hired investment bank Evercore to advise on the process, which is currently at an early stage, two of the people said, speaking on condition of anonymity to discuss confidential information. The plans could change and a sale may not materialize, they cautioned. Waystar declined to comment. Evercore did not immediately respond to a request for comment. Waystar's market value has fallen to roughly $4.8 billion after a 24% slide in its share price this year amid a broader selloff in the software sector. An auction process could gauge whether investor appetite for software businesses is returning. Waystar sought to position itself as a healthcare software company, selling technology to automate and manage administrative work, rather than as a healthcare services business that relies more heavily on people to perform those tasks. The strategy aimed to win the higher valuations typically afforded to technology companies. Investors initially embraced the story, helping drive the shares from $20 to a 2025 peak of $45, but the stock later came under pressure as investors grew concerned that advances in artificial intelligence could disrupt software companies, Morgan Stanley analysts said in a report in July. Waystar was formed in a 2017 merger between healthcare revenue management companies Zirmed and Navicure. Its biggest backers, buyout firm EQT, the Canada Pension Plan Investment Board and alternative investment firm Bain Capital, took it public in 2024. EQT remains the company's largest shareholder with a 13% stake, followed by CPPIB with 10% and BlackRock Institutional Trust Company with 8%, according to LSEG data. EQT declined to comment. CPPIB did not immediately respond to a request for comment. BlackRock declined to comment. (Reporting by Isla Binnie, Sabrina Valle, and Milana Vinn in New York; Editing by Echo Wang and Chris Reese)
Waystar launches new agentic solutions transforming AI into action across the revenue cycle. Aug 26, 2026, 11:21 ET Waystar AltitudeAI(TM) innovations autonomously execute work, connect intelligence to action, and realize significant outcomes for providers LEHI, Utah and LOUISVILLE, Ky., Aug. 26, 2026 /PRNewswire/ - Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today unveiled new Waystar AltitudeAI-powered agentic capabilities that autonomously take action across critical revenue cycle workflows, advancing the company's vision for an autonomous revenue cycle. Built on Waystar's end-to-end platform, payer connectivity, and proprietary data spanning more than 7.5 billion transactions and approximately 60% of U.S. patients, these innovations advance Waystar's ability to drive AI from insight to execution. "Agentic intelligence is a critical layer for the autonomous revenue cycle," said Matt Hawkins, Chief Executive Officer of Waystar. "By combining AI with the breadth of our data, payer intelligence, and connected workflows, Waystar increasingly identifies what needs attention and deploys specialized agents to pursue resolution. As the system of action for healthcare revenue cycle, we are helping providers reduce administrative work, accelerate financial outcomes, and fundamentally change how they operate." The latest Waystar AltitudeAI innovations include: Autonomous claim resolution Denied claims are one of the most challenging, and growing, obstacles for healthcare organizations. While payers ultimately pay approximately 70% of initially denied claims, this often occurs only after providers invest additional time and resources in rework. Waystar is introducing the industry's first autonomous claim resubmission capability to move eligible rejected and denied claims toward resolution with minimal human intervention. Waystar agents interpret payer responses, apply payer-specific intelligence, determine the appropriate next action, and automatically resubmit eligible claims. By reducing delays and manual rework between payer response and resubmission, Waystar can help providers accelerate reimbursement and improve accounts receivable performance. Conversational revenue cycle intelligence Healthcare organizations generate vast amounts of operational and financial data but identifying the root cause of performance issues can still require significant manual analysis. Waystar is embedding conversational AI into its next-generation analytics capabilities, allowing users to ask questions in natural language and rapidly identify trends, root causes, and financial impact without manually analyzing complex datasets. Early adopters have reported up to a 75% reduction in time spent on data analysis[1], enabling teams to move more quickly from insight to action and focus resources where they can have the greatest financial impact. Agentic clinical documentation Building on agentic clinical capabilities introduced earlier this year, Waystar is expanding AltitudeAI across clinical documentation workflows. Waystar agents can now in seconds analyze approximately 30,000 data points within the medical record, synthesize relevant clinical information, make high-confidence recommendations, and organize supporting evidence for specialist review. Waystar expects the agentic capability to reduce review time by approximately 25%, helping clinical documentation teams work more efficiently while supporting greater accuracy and appropriate reimbursement. Agentic patient financial engagement Patients now account for more than $556 billion in annual out-of-pocket healthcare spending, increasing the importance of clear, personalized financial experiences. Waystar is advancing an AltitudeAI-powered agentic concierge designed to proactively guide patients through their financial responsibility. Using context from across the patient financial journey, the agent can deliver more relevant and personalized interactions, helping patients understand what they owe, why they owe it, and how to resolve their balance, while reducing routine administrative burden for healthcare organizations. Waystar will showcase these innovations during its Fall Innovation Showcase today at 11:30 a.m. ET, as part of Waystar True North(TM), the company's annual client conference. More than 600 healthcare experts are attending the conference to explore the next generation of healthcare revenue cycle innovation and the continued evolution toward an autonomous future. The Innovation Showcase will be livestreamed and is available to the public here. About Waystar Waystar's mission-critical software is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance. Waystar serves over 30,000 clients, representing over 1 million distinct providers, including 16 of 20 institutions on the U.S. News Best Hospitals list. Waystar's enterprise-grade platform annually processes over 7.5 billion healthcare payment transactions, including over $2.4 trillion in annual gross claims and spanning approximately 60% of U.S. patients and one in three U.S. hospital discharges. Waystar strives to transform healthcare payments so providers can focus on what matters most: their patients and communities. Discover the way forward at waystar.com. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the expected capabilities, benefits, and performance of Waystar's products and solutions, including Waystar AltitudeAI and its agentic claim resubmission, conversational analytics, patient financial engagement, and clinical documentation capabilities; expected improvements in claim resolution, revenue cycle efficiency, clinical documentation workflows, and patient collections; anticipated reductions in manual effort, administrative burden, and cost to collect for providers; and Waystar's vision for the autonomous revenue cycle. Forward-looking statements may be identified by words such as "anticipate," "believe," "expect," "may," "plan," "will," "designed to," "estimate," and the negative version of these words, or similar terms and phrases that are intended to identify forward-looking statements. These statements are based on current expectations and are subject to risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. These risks include, but are not limited to, variability in client adoption and results; uncertainty in market size estimates derived from internal analysis and third-party data; variability in AI-driven claims matching accuracy across payers; changes in payer resubmission, appeals, and recoupment processes; regulatory developments affecting the use of artificial intelligence in healthcare; reliance on third-party technology platforms and partnerships; changes in healthcare reimbursement policies or regulations; competitive pressures; and other risks described in Waystar's Annual Report on Form 10-K for the year ended December 31, 2025, Quarterly Reports on Form 10-Q for the quarters ended March 31, 2026 and June 30, 2026, and subsequent SEC filings. Actual results may differ materially. Except as required by law, Waystar undertakes no obligation to update forward-looking statements. [1] Reductions in time spent may vary by organization and use case. SOURCE Waystar
Waystar has appointed two executives to accelerate innovation and growth in healthcare payment software. Amit Khanna joins as chief product and technology officer, bringing over 25 years of enterprise technology experience. He most recently led healthcare at Salesforce, where he directed AI strategy and product development, including Agentforce for Health. Todd Woods, a 24-year Waystar veteran, has been named chief commercial officer. He previously led the company's ambulatory, enterprise, channel, and business development growth. The appointments aim to advance Waystar's vision for an autonomous revenue cycle through AI-powered solutions and broader client adoption. The company serves over 30,000 clients representing more than one million providers and processes over 7.5 billion healthcare payment transactions annually, including over $2.4 trillion in gross claims.
Waystar expands executive leadership to accelerate innovation and growth. Published on August 25, 2026 Appointments extend world-class technology expertise and commercial leadership to advance Waystar's vision for the autonomous revenue cycle LEHI, Utah and LOUISVILLE, Ky., August 25, 2026 - Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today announced two executive leadership appointments designed to accelerate innovation, client adoption, and durable growth. Amit Khanna is joining Waystar as Chief Product and Technology Officer, bringing more than 25 years of enterprise technology experience, most recently leading healthcare at Salesforce, and a track record of building and scaling innovative healthcare software. Todd Woods, a 24-year Waystar veteran, has been named Chief Commercial Officer, bringing deep client and market expertise to Waystar's commercial strategy and continued growth. "The revenue cycle is entering a fundamentally new era, where intelligent technology will increasingly orchestrate complex workflows and take action toward resolution," said Matt Hawkins, Chief Executive Officer of Waystar. "Amit brings world-class technology leadership and a track record of building enterprise platforms that healthcare organizations trust. Todd brings unmatched knowledge of our clients, our market, and how to translate innovation into growth. Together, they strengthen an exceptional leadership team and position Waystar to move even faster toward future opportunities ahead." Khanna previously served as Senior Vice President and General Manager at Salesforce, where he led the company's global healthcare business and directed its AI strategy, product direction and go-to-market execution. During his tenure, he led the development of innovative enterprise AI solutions for healthcare organizations, including Agentforce for Health. Prior to Salesforce, Khanna held senior technology leadership roles at SAP and First Data. In his new role, Khanna will lead Waystar's product and technology strategy as the company continues to invest in AI, automation and platform innovation and advances orchestration of an agentic network for clients. Most recently, Woods led Waystar's ambulatory, enterprise, channel, and business development growth. He has played a central role in the company's expansion across healthcare to now serve over one million providers across every care setting, and in building the commercial model supporting the company's sustained growth. As Chief Commercial Officer, Woods leads Waystar's commercial strategy, strengthening client relationships, and expanding the reach and adoption of Waystar's end-to-end platform reshaping the healthcare revenue cycle. Together, these appointments will strengthen Waystar's execution against its autonomous revenue cycle vision by accelerating the development of differentiated AI-powered solutions and translating innovation into broader client adoption and commercial growth. About Waystar Waystar's mission-critical software is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance. Waystar serves over 30,000 clients, representing over 1 million distinct providers, including 16 of 20 institutions on the U.S. News Best Hospitals list. Waystar's enterprise-grade platform annually processes over 7.5 billion healthcare payment transactions, including over $2.4 trillion in annual gross claims and spanning approximately 60% of U.S. patients and one in three U.S. hospital discharges. Waystar strives to transform healthcare payments so providers can focus on what matters most: their patients and communities. Discover the way forward at waystar.com. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "future," "will," "seek," "foreseeable," the negative version of these words, or similar terms and phrases are intended to identify forward-looking statements. These statements include, but are not limited to, statements regarding leadership transitions and organizational restructuring, the anticipated contributions of new members of the management team, Waystar's product strategy and innovation roadmap, the expected benefits of unifying product and technology functions, and Waystar's growth strategy and strategic direction, including its vision for the autonomous revenue cycle. Forward-looking statements are based on Waystar's current expectations and assumptions and are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks include those described under "Risk Factors" in Waystar's most recent Annual Report on Form 10-K and its subsequent filings with the U.S. Securities and Exchange Commission. Forward-looking statements speak only as of the date of this release, and Waystar undertakes no obligation to update any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by law.
Find jobs on Simplify and start your career today
Industries
Enterprise Software
Fintech
Financial Services
Healthcare
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Louisville, Kentucky
Founded
2000
Find jobs on Simplify and start your career today